Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2783383722;83723;83724 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
N2AB2619278799;78800;78801 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
N2A2526576018;76019;76020 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
N2B1876856527;56528;56529 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
Novex-11889356902;56903;56904 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
Novex-21896057103;57104;57105 chr2:178562635;178562634;178562633chr2:179427362;179427361;179427360
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-90
  • Domain position: 68
  • Structural Position: 100
  • Q(SASA): 0.3825
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/R None None 0.999 D 0.881 0.562 0.794854992122 gnomAD-4.0.0 3.44414E-06 None None None None N None 0 0 None 0 0 None 0 0 4.50988E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.5077 ambiguous 0.6231 pathogenic -0.368 Destabilizing 0.978 D 0.725 prob.delet. N 0.495965316 None None N
G/C 0.6876 likely_pathogenic 0.798 pathogenic -0.884 Destabilizing 1.0 D 0.859 deleterious None None None None N
G/D 0.6913 likely_pathogenic 0.8462 pathogenic -0.576 Destabilizing 0.995 D 0.813 deleterious None None None None N
G/E 0.7854 likely_pathogenic 0.9099 pathogenic -0.737 Destabilizing 0.999 D 0.867 deleterious N 0.51242373 None None N
G/F 0.9427 likely_pathogenic 0.9701 pathogenic -1.032 Destabilizing 1.0 D 0.87 deleterious None None None None N
G/H 0.8757 likely_pathogenic 0.9389 pathogenic -0.584 Destabilizing 1.0 D 0.862 deleterious None None None None N
G/I 0.9063 likely_pathogenic 0.9645 pathogenic -0.464 Destabilizing 1.0 D 0.878 deleterious None None None None N
G/K 0.915 likely_pathogenic 0.9645 pathogenic -0.866 Destabilizing 0.999 D 0.873 deleterious None None None None N
G/L 0.9166 likely_pathogenic 0.951 pathogenic -0.464 Destabilizing 1.0 D 0.874 deleterious None None None None N
G/M 0.9028 likely_pathogenic 0.9505 pathogenic -0.456 Destabilizing 1.0 D 0.855 deleterious None None None None N
G/N 0.5434 ambiguous 0.6437 pathogenic -0.492 Destabilizing 0.707 D 0.665 neutral None None None None N
G/P 0.9886 likely_pathogenic 0.9952 pathogenic -0.398 Destabilizing 1.0 D 0.888 deleterious None None None None N
G/Q 0.829 likely_pathogenic 0.9144 pathogenic -0.797 Destabilizing 1.0 D 0.886 deleterious None None None None N
G/R 0.8732 likely_pathogenic 0.9429 pathogenic -0.391 Destabilizing 0.999 D 0.881 deleterious D 0.52717385 None None N
G/S 0.2905 likely_benign 0.3868 ambiguous -0.667 Destabilizing 0.99 D 0.787 deleterious None None None None N
G/T 0.6122 likely_pathogenic 0.7526 pathogenic -0.759 Destabilizing 0.999 D 0.857 deleterious None None None None N
G/V 0.832 likely_pathogenic 0.9247 pathogenic -0.398 Destabilizing 0.999 D 0.875 deleterious N 0.521186369 None None N
G/W 0.9029 likely_pathogenic 0.9564 pathogenic -1.175 Destabilizing 1.0 D 0.857 deleterious None None None None N
G/Y 0.8778 likely_pathogenic 0.9373 pathogenic -0.831 Destabilizing 1.0 D 0.87 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.